Enliven Therapeutics, Inc. · NASDAQ:ELVN

Orbimed Advisors LLC reported a 9.50% stake in Enliven Therapeutics, Inc. (Schedule 13D/A)

Event Jun 22, 2026 · Filed Jun 24, 2026

Orbimed Advisors LLC reported a 9.50% stake in Enliven Therapeutics, Inc., 6,774,507 shares, with active intent on Jun 22, 2026. Filed Jun 24, 2026 (Schedule 13D/A).

Stake
9.50%
Shares
6,774,507
Intent
Active
What changed
Stake changed
Filed together
4 holders

The filing in full

HolderStakeShares
ORBIMED ADVISORS LLC9.50%6,774,507
ORBIMED CAPITAL GP VII LLC9.20%6,555,102
ORBIMED GENESIS GP LLC0.30%219,405
ORBIMED CAPITAL LLC0%0

Source

View original at SEC

Related